Calgary, Alberta--(Newsfile Corp. - November 20, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient's…
NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era…
GT-02287 reduces mitochondrial stress and enhances neuronal survival in MPP+ treated rat dopaminergic neurons GT-02287 decreases staining for MIRO1, suggesting…
Brain activity study shows Neuro-Contextual advertising drives 3.5x higher neural engagement and 26% lift in positive, action-driving response NEW YORK,…
BURLINGTON, Mass., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development…
Teva Launches Teva Rise Teva Launches Rise - Global Open Innovation Platform First cohort features 7 real-world challenges across R&D,…
South Florida hospital recognized at the highest level of digital care excellence MIAMI BEACH, Fla., Nov. 18, 2025 /PRNewswire/ --…
BOSTON, Nov. 18, 2025 /PRNewswire/ -- Linus Health, an AI-driven brain health company pioneering early detection of cognitive impairment and…
Initiative led by researchers in Australia and Japan aims to map cancer and immune interactions to advance precision oncology across…
More than 20 years of financial and operational leadership in biopharma, including $170M+ in capital raised, global commercialization experience, and…